Back to Search

Ribociclib Succinate – Uses, Dosage, and Brands in UAE

Brand Name: KISQALI
Strength: 200 mg | Form: Tablets
Price in UAE: AED 25634.50
Available in UAE pharmacies

About Ribociclib Succinate

Class: | Antineoplastic agent, CDK4/6 inhibitor Use: | Treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer in combination with an aromatase inhibitor as initial endocrine-based therapy in postmenopausal women, or in combination with fulvestrant in patients with disease progression following endocrine therapy. Adult dose: | 600 mg orally once daily for 21 consecutive days followed by 7 days off treatment in a 28-day cycle. Pedi

Drug Class

Antineoplastic agent, CDK4/6 inhibitor

Uses & Indications

Treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer in combination with an aromatase inhibitor as initial endocrine-based therapy in postmenopausal women, or in combination with fulvestrant in patients with disease progression following endocrine therapy.

Storage Requirements

Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F). Keep in original container and protect from moisture.

Manufacturer & Packaging

Manufacturer: Novartis Pharmaceuticals Corporation, U.S.A

Package Size

63s (21s Blister x 3)

Price & Supplier

Price in UAE: AED 25634.50

Dosage Information

Adult Dose

600 mg orally once daily for 21 consecutive days followed by 7 days off treatment in a 28-day cycle.

Pediatric Dose

Safety and efficacy in pediatric patients have not been established; not recommended for use in children.

Side Effects

Common side effects include neutropenia, nausea, fatigue, diarrhea, vomiting, liver enzyme elevations, and rash.

Contraindications & Precautions

Known hypersensitivity to ribociclib or any component of the formulation; concurrent use with strong CYP3A inhibitors.

Important Warnings

Risk of severe neutropenia, hepatotoxicity, QT interval prolongation, and potential for embryo-fetal toxicity; monitor blood counts and liver function tests regularly.

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. The information presented here is specific to medicines available in UAE pharmacies and is regularly updated to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.

View All Antineoplastic agent, CDK4/6 inhibitor Medicines Browse All Categories